| Literature DB >> 31891452 |
Satoshi Hoshide1, Kazuomi Kario1, Naoko Tomitani1, Tomoyuki Kabutoya1, Yook-Chin Chia2,3, Sungha Park4, Jinho Shin5, Yuda Turana6, Jam Chin Tay7, Peera Buranakitjaroen8, Chen-Huan Chen9, Jennifer Nailes10, Huynh Van Minh11, Saulat Siddique12, Jorge Sison13, Arieska Ann Soenarta14, Guru Prasad Sogunuru15,16, Apichard Sukonthasarn17, Boon Wee Teo18, Narsingh Verma19, Yuqing Zhang20, Tzung-Dau Wang21, Ji-Guang Wang22.
Abstract
Unlike other international guidelines but in accord with the earlier Japanese Society of Hypertension (JSH) guidelines, the 2019 JSH guidelines ("JSH 2019") continue to emphasize the importance of out-of-office blood pressure (BP) measurements obtained with a home BP device. Another unique characteristic of JSH 2019 is that it sets clinical questions about the management of hypertension that are based on systematic reviews of updated evidence. JSH 2019 states that individuals with office BP < 140/90 mm Hg do not have normal BP. The final decisions regarding the diagnosis and treatment of hypertension should be performed based on out-of-office BP values together with office BP measurements. For hypertensive adults with comorbidities, the office BP goal is usually <130/80 mm Hg and the home BP goal is <125/75 mm Hg. Recommendations of JSH 2019 would be valuable for not only Japanese hypertensive patients but also Asian hypertensive patients, who share the same features including higher incidence of stroke compared with that of myocardial infarction and a steeper blood pressure-vascular event relationship.Entities:
Keywords: elderly population; guideline; home blood pressure; hypertension
Mesh:
Substances:
Year: 2019 PMID: 31891452 PMCID: PMC8030065 DOI: 10.1111/jch.13763
Source DB: PubMed Journal: J Clin Hypertens (Greenwich) ISSN: 1524-6175 Impact factor: 3.738